ESMO 2025: OncoDaily LIVE Coverage
OncoDaily Party Berlin 2025
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025
DESTINY-Breast11 at ESMO 2025: Neoadjuvant T-DXd-THP Outperforms ddAC-THP in HER2-Positive Early Breast Cancer
David Fredrickson: Historic Agreement to Lower Medicine Costs and Protect US Biopharma Innovation
COMPASSION-15 Trial at ESMO 2025: Cado Plus Chemotherapy Extends Survival in HER2-Negative Gastric Cancer
Elen Baloyan: The Power Behind the Voice of Oncology
Nina Niu Sanford: ASCO LDP Class of 2025-26
Winette van der Graaf: The HOLISTIC Study on Quality of Life Impact in Soft Tissue Sarcoma
